Based in Las Vegas, Nevada, CV Sciences operates through two divisions, Specialty Pharmaceuticals and Consumer Products. The company develops and commercializes prescription drugs based on synthetic CBD. CBD giant CV Sciences reports $9 million loss in first quarter (This story has been updated to provide commentary from company executives on the results.) CV Sciences, a CBD specialist based in Las Vegas, reported revenue of $14.9 million for its first quarter ended March 31, up 85% from the same period a year ago. Charlotte’s Web, CV Sciences Facing Lawsuits Over ‘Mislabeled’
Learn about CV Sciences and their latest natural product offerings, as well as end-consumer products containing the hemp plant extract, cannabidiol (CBD).
CV Sciences Inc. (CVSI) Stock Message Board - InvestorsHub
20 Sep 2018 CV Sciences, a public company, has received self-affirmed GRAS status, demonstrating the safety of its "hemp-derived CBD gold extract.
Description. Each 1.3 bottle of PlusCBD™ Oil Extra-Strength Balm contains: 100mg of CBD Made using our Gold Formula No artificial dyes or fragrances 10 Oct 2016 CV Sciences is a publicly traded company, formerly known as According to SPINs, the CV Sciences' consumer brand, PlusCBD Oil™, is the 26 Nov 2019 Meanwhile, three CBD-focused companies—Charlotte's Web, Medical Marijuana, Inc. and CV Sciences—were trading down as much as CV Sciences are integrating science and nature, improving health and Makers of PlusCBD Oil, the leading brand in hemp-derived CBD oil products available 28 Oct 2019 The sense of a rebound underway in the cannabis and CBD stocks continues to grow, as CV Sciences Inc (OTCMKTS:CVSI) shares appear to
CV Sciences Aktie | Aktienkurs | Chart | A2ALU7